The Global In-Vitro Diagnostics Instruments Market is estimated to be USD 22.34 Bn in 2021 and is expected to reach USD 32.7 Bn by 2026, growing at a CAGR of 7.92%.
The development of condition-specific markers and tests and the paradigm shift from traditional diagnostics to a new generation of diagnostics are anticipated to create opportunities for the emerging markets.
By Instruments, the market is classified into Fully-Automated Instruments, Semi-Automated Instruments, And Others. Amongst all, the Fully-Automated Instruments segment is estimated to hold the highest market share during the forecast period.
By Technology, the market is classified as Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis, Other Technologies, and Others. Amongst all, the Immunoassay/Immunochemistry segment is estimated to hold the highest market share during the forecast period.
By Application, the market is classified as Infectious Diseases, Diabetes, Oncology, Cardiology, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Nephrology, and Others. Amongst all, the Infectious Diseases segment is estimated to hold the highest market share during the forecast period.
By End-User, the market is classified as Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing, Self-Testing, Academic Institutes, and Others. Amongst all, the Hospital Laboratories segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
2. Thermo Fisher Scientific launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use - 25st March 2021
Market Dynamics
The factors contributing towards the growth of the In-vitro diagnostics instruments market are the increasing prevalence of chronic and infectious diseases, rising geriatric population, awareness growing for self-testing, and personalized medicines. The increasing product launches with automated instruments and equipment in laboratories and growing awareness of Point-of-care testing have further escalated the market growth. The global in-vitro diagnostic instrument market may hinder due to the unfavorable reimbursement policy and high cost of devices.The development of condition-specific markers and tests and the paradigm shift from traditional diagnostics to a new generation of diagnostics are anticipated to create opportunities for the emerging markets.
Market Segmentation
The Global In-Vitro Diagnostics Instruments Market is segmented further based on Instruments, Technology, Application, End-Users, and Geography.By Instruments, the market is classified into Fully-Automated Instruments, Semi-Automated Instruments, And Others. Amongst all, the Fully-Automated Instruments segment is estimated to hold the highest market share during the forecast period.
By Technology, the market is classified as Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis, Other Technologies, and Others. Amongst all, the Immunoassay/Immunochemistry segment is estimated to hold the highest market share during the forecast period.
By Application, the market is classified as Infectious Diseases, Diabetes, Oncology, Cardiology, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Nephrology, and Others. Amongst all, the Infectious Diseases segment is estimated to hold the highest market share during the forecast period.
By End-User, the market is classified as Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing, Self-Testing, Academic Institutes, and Others. Amongst all, the Hospital Laboratories segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Abbott Launches Panbio™ COVID-19 Antigen Self-Test in India - 12th July 20212. Thermo Fisher Scientific launches the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for In Vitro Diagnostic Use - 25st March 2021
Company Profiles
Some of the companies covered in this report are Abbott Laboratories, bioMérieux, Illumina, Ortho Clinical Diagnostics, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Sysmex Corporation, Fisher Scientific International, Becton, Dickinson and Company, etc.Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.Why buy this report?
- The report offers a comprehensive evaluation of the Global In-Vitro Diagnostics Instruments Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global In-Vitro Diagnostics Instruments Market
What is the estimated value of the Global In-Vitro Diagnostics Instruments Market?
What is the growth rate of the Global In-Vitro Diagnostics Instruments Market?
What is the forecasted size of the Global In-Vitro Diagnostics Instruments Market?
Who are the key companies in the Global In-Vitro Diagnostics Instruments Market?
Report Attribute | Details |
---|---|
No. of Pages | 203 |
Published | June 2021 |
Forecast Period | 2021 - 2026 |
Estimated Market Value ( USD
| USD 22340 Million |
Forecasted Market Value ( USD
| USD 32700 Million |
Compound Annual Growth Rate | 7.9% |
Regions Covered | Global |
No. of Companies Mentioned | 27 |
Table of Contents
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global In-Vitro Diagnostics Instruments Market, By Instruments
7 Global In-Vitro Diagnostics Instruments Market, By Technology
8 Global In-Vitro Diagnostics Instruments Market, By Application
9 Global In-Vitro Diagnostics Instruments Market, By End-Users
10 Global In-Vitro Diagnostics Instruments Market, By Geography
11 Competitive Landscape
12 Company Profiles
13 Appendix
Companies Mentioned
- Abbott Laboratories
- bioMérieux
- Illumina
- Ortho Clinical Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Thermo Fisher Scientific
- Sysmex Corporation
- Fisher Scientific International
- Becton, Dickinson and Company
- Hologic
- Danaher Corporation
- Bio-Rad Laboratories
- Grifols
- Arkray
- Surmodics
- WerfenLife
- PerkinElmer
- DiaSorin
- Qiagen
- Quest Diagnostics
- Quidel Corporation
- Philips Healthcare
- SpeeDx Diagnostics
- GenomeMe
- Aniara Diagnostica
- Charles River Laboratories International